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 In this study, the in vivo reproducibility of stochastic predictors and BMD values 
from Dual- Energy X-ray Absorptiometry (DXA) were assessed at two different 
anatomic sites: hip and spine. Measurement of bone mineral density (BMD) derived from 
DXA has been widely used as a diagnostic tool for osteoporosis. BMD has been used as a 
representative value for bone strength and fracture risk, but only represents a part of both.  
In order to better understand fracture risk, the use of grayscale images from DXA scans 
has been implemented in enhancing the prediction of bone strength and fracture risk. The 
use of stochastic predictors derived from DXA scans is a recent method of evaluating the 
bone quality and fracture risk. The goal of this study was to examine the precision of 
stochastic predictors and BMD values from DXA scans. The study involved 15 
postmenopausal women over the age of 55 with no history of osteoporotic fractures. 
Three sets of in vivo DXA scans were taken at 2 different scan sites (hip and spine) in the 
posterior-anterior projection. An International Society for Clinical Densitometry certified 
technician performed the scans on a Hologic densitometer (QDR Discovery W, Bedford, 
MA). Lumbar spine and hip values of BMD were assessed for precision from the DXA 
program. Using the same data from the DXA scans, an experimental variogram was used 
vii	
	
to derive stochastic predictors. The precision values, expressed as RMS-%CV, for the 
BMD measurement were computed. The RMS-%CV values of stochastic predictors for 
the hip and lumbar spine was also used to determine reproducibility of measurement. The 
study found that although the lumbar vertebrae and the total hip RMS-%CV were within 
the recommended values as outlined by the ISCD, the stochastic predictors did not 
coincide in precision. The stochastic predictors are a relatively new imaging process that 
has no other study to compare to. The significance of the RMS-%CV in the stochastic 
predictors is limited by the amount of data available and the nature of inhomogeneity, 
represented by stochastic predictors.
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CHAPTER ONE 
INTRODUCTION AND GENERAL INFORMATION 
 Spine and hip fractures are common types of osteoporotic fractures. With 
a growing population at risk of developing osteoporosis, treatment and prevention of 
osteoporosis are becoming a major concern in the health care of the elderly population. 
Osteoporosis is a skeletal disease that is degenerative in nature. A gradual loss of bone 
mass and deterioration of bone microarchitecture cause a reduction in bone stiffness and 
strength. The result is an increased risk of fragility fractures. Diagnosis with early 
intervention is vital for treatment.  
1.1 Osteoporosis and Bone Fragility  
Bones make up the structure of our lives. For bones, we often look at gross 
anatomy to understand the function of the bone. Bone represents a dynamic relation 
between function and structure. Bone is unique in that it is continuously regenerated and 
restructured throughout our life. Bone responsiveness to mechanical, hormonal, and 
nutritional factors with its relation to bone structure encapsulates a very diverse category 
of study. One section of study of particular importance is how to determine the strength 
of bones. It is the underlying structure within the bone that is an important factor in 
understanding the quality of bones to its function.  That is, we must look at how strong 
our bones are in order to understand their ability to function. Bones make up the rigid 
bodies against which muscles pull. The body consists of lever systems to produce 
movement. As bones and muscles work in conjunction, they provide movement. Along 
with movement, bone structures also provide protection to vital organs. It should also be 
noted that bones and teeth store up to 99% of the calcium within the human body 
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(Jenkins, Kemnitz, & Tortora, 2007). With this in mind, it should be considered that bone 
health is essential for quality of life. 
Bone strength is determined by two components: bone mass and bone quality 
(NIAMS, 2008). Bone mass is indicative of the amount of bone available. Bone is 
comprised of collagen and mineral. Mineral accounts for most of bone mass (Blake, 
Adams, & Bishop, 2013). 
Bone quality includes a number of parameters, such as micro-architecture, bone 
turnover and mineralization (Bandirali et al., 2015). The bone micro-architectures or the 
geometric positioning of osteocytes can describe bone quality. As the structure of bone is 
reabsorbed and deposited, also known as bone remodeling, the pattern in which bone is 
reabsorbed is representative of the stress which bone is placed under (Jenkins et al., 
2007). As bone is stressed, bone architecture will change to modify the mechanical 
strength of bone and its ability to resist stress (Blake et al., 2013). 
As mentioned before, bone architecture is important in determining the function 
and strength of bone. In regard to this, organization of bone tissue within the bone is 
often separated into cortical (compact) and cancellous (trabecular/spongy) bone.  Cortical 
bone is characterized by being resistant against bending and torsion forces. Compact 
bone makes up roughly 80% of skeletal mass. The cortical component of bones is often 
found surrounding the internal cavity of bones as protective layer. Trabecular bone makes 
up roughly 20% of the mass of bones. For cancellous bones, its architecture is set with 
high porosity as a way to respond and resist compression forces (Clarke, 2008). By 
relying exclusively on bone mass as a value to determine strength, the distinction 
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between the two cannot be made. Nor can the discrepancies between bone density and the 
bones ability to resist specific ground forces. 
Osteoporosis is a disease characterized by the reduction of bone strength that 
increases the risk of bone fractures (NIAMS, 2014). It is sometimes referred to as a 
“silent disease” as people often do not realize that their bones are porous until a fracture 
has already occurred.  Osteopenia is a “softening” of the bones that precedes 
osteoporosis. Any person can run the risk of developing weak bones. The most prevalent 
risk factor to consider is age. As the population begins to increase in age, the risk of bone 
fractures will increase as well. It is predicated that by 2020, half of the population within 
the United States will be over 50. The most commonly reported fracture sites are the 
spine, hip and wrist. With the fracture risk increase, an increase in mortality has been 
reported. According to the 2012 Surgeon General’s Report, “If you are elderly, a broken 
hip makes you up to four times more likely to die within three months. If you survive, the 
injury often causes your health to spiral downward. One in five people with a hip fracture 
end up in a nursing home within a year ” (WHO, 2004). With osteoporosis, the loss of 
trabecular bone mass is considered more damaging to the overall structures. The surface 
area of the trabecular bone increases the amount of bone turnover as compared to 
compact bone (Clarke, 2008). This higher surface area results in a higher rate of mineral 
reabsorption. 
1.2 Criteria for Osteoporosis 
One of the most obvious methods of determining weakness within the bones of a 
patient would be when fracture occurs. As the micro-architecture of the bone diminishes, 
so does the ability of bone to resist stress. Often, many individuals do not realize that 
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their bones are weak until the bones themselves break. Bone mineral density (BMD) 
represents the mineral content per area and is expressed in g/cm2. In order to act before 
the bone degrades to a critical level, most clinicians use a bone mineral density value to 
understand the amount of minerals per unit of area to determine the strength of the bone 
(OSG, 2004). A BMD score is compared to healthy individual’s average BMD scores. 
The amount that the values differ from the norm is measured as the T- score.  The World 
Health Organization has compiled the following values for diagnosis: T-scores above 
−1.0 are normal; T-scores between −1.0 and −2.5 are osteopenia; T-scores −2.5 or below 
are osteoporotic. 
1.3 DXA and BMD 
The gold standard for determining BMD is dual energy x-ray absorptiometry 
(DXA).  DXA scans are widely used to determine BMD of the wrist, lumbar spine, hip 
and whole body (Blake, et al., 2013). The wide use of DXA as a diagnostic tool comes 
from the relative ease of use, the precision of values and the ability to conduct DXA 
scans with low amount of radiation exposure to patients. DXA scans are also inexpensive 
as compared to other options that measure bone density. There is a 70% correlation 
between bone density and bone strength (NIAMS, 2014). 
The precision of DXA scan values is one of the main reasons for its widespread 
use as a diagnostic tool. DXA is currently used to measure the BMD of bones in order to 
determine osteoporosis, assessment of fracture risk and the progression of treatment.  
When looking at site section to determine BMD values, it has been documented that hip 
scans are the most reliable measurement site for predicting hip fracture risk. Lumbar 
spine DXA scans have been used in monitoring the effectiveness of treatment. Clinicians 
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use BMD values from DXA scans to determine osteoporosis and low bone mass in 
postmenopausal women (Blake et al., 2013). 
DXA is widely used in clinical settings. DXA machines have the advantages of 
high precision, short scanning times, low radiation dose, and improved calibration 
stability in the clinical environment. The main advantage of DXA is measuring BMD. 
With BMD, values can be used to assess the possibility of bone fractures.  The lumbar 
spine and hip are the two most common sites chosen for BMD measurement. Both areas 
are of high interest for clinicians, as they are the most common sites for osteoporotic 
fractures. 
1.4 Current Limitations of DXA 
Currently, DXA scans to measure BMD values are taken for select populations in 
order to diagnose osteoporosis. No definitive standards exist for adjusting BMD for bone 
size, pubertal stage, skeletal age, or body composition for growing children. For women 
aged 65 and older, and postmenopausal women under age 65 with risk factors for 
fractures, BMD values are used to determine osteoporosis.  Women during the 
menopausal transition with clinical risk factors for fracture, such as low bodyweight, 
prior fracture or high-risk medication use are also included (Lewiecki et al., 2008). 
Hormonal Imbalance (Menopause, Amenorrhea, Age) could be a reason for bone density 
discrepancies in populations. When estrogen has been lost, bone mineral is also lost 
(NIAMS, 2014). In general, smaller bones have smaller BMD values. Populations who 
have smaller bones will have smaller BMD value regardless of architecture. Men aged 70 
and older and men under the age of 70 with clinical risk factors for fracture also undergo 
BMD testing to diagnose osteoporosis. Osteoporosis cannot be diagnosed in men under 
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age 50 on the basis of BMD alone. Lastly, adults with a disease or condition associated 
with low bone mass or bone loss from taking medications associated with low bone mass 
or bone loss also use BMD values to determine osteoporosis. Even within these specific 
populations, fracture risk cannot be predicted for individuals on the basis of BMD alone 
(Lewiecki et al., 2008). Reasons for the secular changes and variations in fracture risk are 
unknown, but cannot be explained completely on the basis of differences in bone mineral 
density (WHO, 2004). 
Although considered the most widely used diagnostic method, DXA scans have 
been widely studied as only a part of bone strength.  Many have discussed the importance 
of architecture within the bone as a significant variable that determines the bone’s 
strength. Architecture, porosity and tissue mineral density are values that can be derived 
from BMD but have not been completely distinguished from each other. When using 
DXA, the assumption that error may occur due to positioning, soft tissue, and possible 
osteophytes (gross deformity) may exist (Rosen et al., 2013). Studies utilizing DXA 
scans make use of trained clinicians and imaging reading to greatly decrease the amount 
of error. The precision of DXA scans has been documented. The accuracy of DXA scans 
as a fracture risk assessment value has often been limited by the inability to incorporate 
structure into the readings (Rosen, et al., 2013).  Although widely used and available, 
BMD values cannot be compared against different devices (Lewiecki, et al., 2008) 
 The DXA protocol derives BMD values from a two-dimensional (2D) alignment. 
This means that only one profile of interest is derived for a given analysis of BMD. By 
using a two-dimensional image to understand a three-dimensional object, much of the 
precision is lost (Khoo et al., 2005). One limitation often cited is that positioning of the 
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bones may change the BMD values.  The ability to correctly position the subject depends 
highly on the skill of the technician (Lewiecki & Lane, 2008). It is also important to note 
that the measurements with DXA, because of the 2D limitation, are affected by bone size 
(Sydney Lou Bonnick, Lewis, 2013). When using digital imaging, each pixel is computed 
as an intensity value. This is a greyscale value. Using greyscale values from DXA scans, 
technicians can compute some microarchitecture values from the 2D scans. 
The International Society of Clinical Densitometry (ISCD) recommends using 
specific sites in order to determine osteoporosis and to monitor treatment of patients 
(Lewiecki, et al., 2008). The ISCD currently recommends measuring the BMD at both 
the Posterior-Anterior (PA) spine and hip in all patients. Lumbar readings should use PA 
L1–L4 for spine BMD measurement. All evaluable vertebrae should be included in the 
measure of BMD and should only be excluded if local structural changes or artifacts 
affect vertebrae. Anatomically abnormal vertebrae may be excluded from analysis if they 
are clearly abnormal and non-assessable within the resolution of the system. The use of 
three vertebrae if four cannot be used or two if three cannot be used is the recommended 
modification for evaluation. Lateral spine measurements should not be used for 
diagnosis, but may have a role in monitoring treatment. For the hip, the femoral neck or 
the total of the proximal femur, whichever is lowest, should be used to calculate BMD.  
The mean hip BMD value can be used for monitoring, with the total hip being preferred.  
Forearm measurements should only be used if hip and/or spine cannot be measured or 
interpreted, or may be used for a diagnosis of hyperparathyroidism in a patient who is 
unable to be properly positioned on the table due to obesity. 
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1.5 Current Improvements over DXA 
1.5.1 Three-Dimensional Imaging Modalities 
An advantage of using 3D imaging techniques is that they can distinguish 
trabecular bone from cortical bone. Currently, the use of computed tomography and 
magnetic resonance imaging is incorporated into both research and some clinical studies 
of osteoporosis. 
Multi-slice spiral Computed Tomography (CT) scanners have been used in vivo 
to evaluate the lumbar spine. CT is considered to achieve a higher resolution than DXA 
scans. However, the ability of CT scans to differentiate between those with and without 
fractures has not been significantly better than that of BMD (Bouxsein, 2003).  
Quantitative Computed Tomography (QCT) was first developed for assessment of 
the spine but has since been applied to the hip and the appendicular skeleton. QCT is 
generally reserved for research purposes due to issues related to feasibility, availability, 
high radiation doses and costs. Standard CT machines can be transformed into QCT 
machines by using a mineral equivalent phantom spine to calibrate the image (Bouxsein, 
2003).   QCT is the only method that allows volumetric evaluation of BMD and which 
also allows cortical and trabecular bone to be measured separately. “This is of particular 
relevance for assessment of corticosteroid-induced osteoporosis and parathyroid hormone 
treatment, where trabecular bone has been shown to be more responsive to change than 
cortical bone (Haugeberg, 2008).” In postmenopausal women with osteoporosis caused 
by long term glucocorticoid treatment but who also received hormone replacement 
therapy, measures of bone density of  their lumbar spines measured by QCT were found 
to be independent predictors of vertebral fractures (Guglielmi, Muscarella, Leone, & Peh, 
2008).  
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High-resolution peripheral quantitative computed tomography (HR-pQCT) is a 3d 
imaging technique that has been shown to be effective in determining the micro 
architecture of trabecular bone both in vivo and in vitro. HR-pQCT has been used in 
research settings to assess the effectiveness of osteoporosis treatments and disease. In 
clinical study, the use of HR-pQCT to determine the micro-architecture for the tibia and 
distal radius has been shown to be useful in predicting the cortical and trabecular 
morphology. This has been useful in evaluating the treatment, micro-architecture and 
bone loss for individuals within these studies (Bouxsein, 2003). This imaging technique 
has yet to become established within the clinical setting. For clinical settings, its 
effectiveness is offset by the limited access and affordability (Bouxsein, 2003).  
High-resolution magnetic resonance imaging is referred to as a direct method for 
three-dimensional imaging of trabecular bone networks. Magnetic resonance imaging 
(MRI) has sufficient spatial resolution and high-contrast resolution and is used in the 
diagnosis of lumbar vertebra diseases. The trabecular properties from MRI have been 
shown to have a close correlation with other measurement of trabeculae from other high 
resolution imaging techniques, like that of HR-pQCT (Dong et al., 2015).   Some MRI 
evaluation techniques developed to understand osteoporosis are MR Relaxometry, high-
resolution MRI, and MR spectroscopy. “MR signal-related relaxometric parameters that 
could be directly or indirectly affected by alterations of susceptibility gradients have 
served as an excellent index for the quantification of trabecular bone status. High-
resolution MRI is referred to as a direct method for two-dimensional or three-dimensional 
imaging of trabecular bone networks” (Koyama, Yoshihara, Kotera, Tamura, & 
Sugimura, 2013). MR spectroscopy, in osteoporosis studies, reflects the changes in the 
10	
	
direct content of water and lipid molecules within bone tissues. The use of MRI in 
clinical evaluation of osteoporosis is often limited by the cost of the procedure (Koyama, 
et al., 2013).	 Future developments need to address the current limitations of high-
resolution MRI, such as the requirement for specialized coils, the limitation to assessment 
at peripheral sites, and the relatively long acquisition times (Dong & Wang, 2013). 
1.5.2 Two-Dimensional Models 
1.5.2.1 Hip Structure Analysis 
In hip structure analysis, the cross-sectional moment of inertia, the section 
modulus, the buckling ratio and the cortical thickness can be obtained from the DXA 
scan at the hip (Bonnick, 2007). Hip structure analysis can either be used by 
measurements at the femoral neck or that are then combined to create a proprietary index 
intended to reflect the bone's ability to withstand forces generated during walking or 
during a fall on the greater trochanter. This is referred to as Femur Strength Index 
(Bonnick, 2007). Another way to use hip structure analysis is when there are multiple 
regions of interest, including the narrow neck, intertrochanteric and the shaft region. The 
narrow neck refers to narrowest portion of the femoral neck. The intertrochanter refers to 
a bisector of the intersection of the femoral neck and shaft axes.  The “shaft region” is 
placed 1.5 times the femoral neck width, distal to the intersection of the neck and shaft 
axes (Bonnick, 2007). 
1.5.2.2 Fractional Risk Assessment Tool (FRAX)  
The World Health Organization (WHO) currently uses a questionnaire that relies 
on BMD values and demographic information to predict bone fracture risk. FRAX is used 
as an assessment tool for the prediction of fractures in men and women. FRAX uses 
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clinical risk factors with or without the use femoral neck bone mineral density to 
determine risk. “Clinical risk factors include age, sex, race, height, weight, body mass 
index, a history of fragility fracture, a parental history of hip fracture, use of oral 
glucocorticoids,” (Unnanuntana, Gladnick, Donnelly, & Lane, 2010). The FRAX 
assessment tool has been shown to have success when predicting long-term fracture risk. 
However, the overlap between risk of fracture and fracture occurrence has been noted to 
be a significant limitation (WHO, 2004).  
1.5.2.2 Fractal analysis 
Fractional analysis is used to find geometric and micro structural features of bone 
from 2D projection image modalities through imaging process techniques. Fractal 
analysis has been used on high-resolution 2D radiography images in both clinical and in 
vitro studies. Fractural geometry is used to define the shape of an object that cannot be 
explained by traditional geometric shapes and sizes. Fractural dimensions are the 
characteristics of the fractural geometry. “Fractal dimension is a measure of how 
complex the structure of a self-similar object is, which is defined as a ratio of the 
logarithm of the number of self-similar pieces to the logarithm of the magnification 
factor”(Dong & Wang, 2013).  The ability of fractal dimensional analysis to predict 
osteoporosis is comparable to BMD of trabecular bone at the radius. It is also noted that 
prediction rates are lower than those of total hip for BMD. Although useful, fractal 
analysis requires a large projection surface and distinguishable textures from high-
resolution images. As DXA images use smaller areas with lower resolution, fractal 
analysis is unsuitable for DXA images (Pothuaud, Carceller, & Hans, 2008). Fractal 
analysis is also used in high-resolution MRI of distal radius from cadavers. The fractal 
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analysis provides the information independent of BMD in predicting failure loads of 
distal radius.  
1.5.2.3 Trabecular Bone Score 
The trabecular bone score (TBS) is currently used to describe the micro-
architecture of bone. It is a textural parameter that uses grey scale images from DXA to 
compute the micro-architecture of bones. It is used as software that analyzes the image 
from a lumbar spine DXA image to compute a unit-less value.  “TBS is a textural grey 
scale index that evaluates pixel gray-level variations in the lumbar spine from a DXA 
image, providing an indirect index of trabecular micro architecture (Rosen, et al., 2013).” 
The bone micro-architectures or the geometric positioning of osteocytes can describe 
bone quality. “A dense trabecular microstructure projected onto a plane generates an 
image containing a large number of pixel value variations of small amplitude. 
Conversely, a 2D projection of a porous trabecular structure produces an image with a 
low number of pixel value variations of high amplitude” (Silva et al., 2015). “TBS is 
determined by a computed variogram of the image of the region of interest from the DXA 
scan. This is calculated as the sum of the squared gray-level differences between pixels at 
a specific distance. The TBS value calculated as the slope of the log-log transform of the 
variogram” (Silva et al., 2014). 
TBS as a predictor of fracture risk is partially independent of central DXA BMD, 
clinical risk factors, and fracture probability estimated by FRAX. TBS may be used to 
determine fracture risk in clinical practice. It should be used in association with FRAX 
and BMD to adjust FRAX-probability of fracture. TBS values, however, should not 
solely be used to determine treatment recommendations, nor can it be used for monitoring 
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bisphosphonate treatment in postmenopausal women with osteoporosis (Rosen, et al., 
2013). 
1.5.2.4 Stochastic Predictors from DXA Scans 
By using stochastic predictors derived from the DXA images, the variation of the 
bone mineral density can give a better assessment of the different areas of the bone. 
Currently, image resolution is a factor that determines how well an imaging technique 
can be used for clinical assessment of bone fragility. Stochastic parameters represent the 
spatial variation within the 2D image. The use of 2D images, like that of DXA, already 
contains this information. Although lower in resolution than other imaging techniques, 
the information from these grey scale images could significantly reduce the importance of 
resolution. Currently, the use of descriptive statistic values, like mean and standard 
deviation, describes the heterogeneity of bone, but does not indicate the spatial qualities 
of bone (Dong & Wang, 2013). Experimental variograms can be used to explain the 
stochastic assessment of inhomogeneity. The variogram is a descriptive statistic that 
characterizes the spatial variation over different areas of bone. For this experiment, this is 
meant to represent the BMD distribution from DXA scans. Spatial variation of BMD map 
from DXA scans is expressed in two variables (semi-variance and lag) using variograms. 
Semi-variance is indicative of the variance within the BMD map. The lag is correlated 
with the smoothness and roughness of variation.  The semi-variance γ(h) is defined as 
half of the expected squared difference between any paired data values {z(x), z(x+h)}: 
21( ) [{ ( ) ( )}]
2
h E z x z x hg = - +
       (1) z is a random function of the bone property that varies continuously in space, x denotes 
the spatial coordinates of locations and h, also known as lag, is a vector representing the 
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Euclidean distance and direction between any two data locations. Simply put, the 
variogram builds from random points within the BMD map. The equation is used to map 
the location and variation between the points. The sill on the variogram indicates second-
order stationarity. The experimental variogram for BMD map of vertebrae is computed as 
an average of semi-variance values at different locations that have the same value of lag: 
( )
2
1
1( ) { ( ) z(x )}
2 ( )
m h
i i
i
h z x h
m h
g
L
-
= - +å
        (2) 
 where m(h) is the number of data pairs { ( ), z(x )}i iz x h+  for observations separated by 
”h.”  For the total hip, an exponential variogram model is used over the experimental 
variogram of the BMD map (Figure 1). For the spine, a hole-effect theoretical variogram 
model is used over the experimental variogram of the BMD map (Figure 1). The model is 
from a set of mathematical functions that describe spatial relationships. The correct 
model is selected by matching the shape of the curve of the variogram to the shape of the 
curve of the math function.  
 
	
Figure 1. Theoretical exponential model (left) and hole-effect model (right) fitted over 
the experimental variogram of the bone mineral density map 
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The mathematical definition of exponential model is given as 
𝑟 ℎ = 𝑐(1 − 𝑒)*+)         (3)  
The mathematical definition of hole-effect model is given as 
sin(h / L)( ) (1 )
(h / )
h c
L
pg
p
= -
        (4)  
(h)g  is the semi-variance as a function of lag (h), L is referred to as the correlation length 
and c is referred to as sill variance of BMD map.  
The data extrapolated from the variogram are used in algorithms to create certain 
features of correlation. These values (correlation length and sill variance) are described 
below. 
Correlation length is the lag distance at which semi-variogram reaches the sill 
value. Correlation length describes the degree of smoothness or roughness in the BMD 
map. A relatively large correlation length implies a smooth variation, whereas a small 
correlation length corresponds to rapid variations of the bone mineral density over the 
spatial domain. 
The sill variance of the variogram is representative of the variance within the 
BMD map. The sill variance is defined as the limit of the experimental variogram tending 
to infinity lag distances. It can be referred to as the "amplitude" or “maximum value” of 
certain component of the semi-variogram.  
Currently, the stochastic predictors from DXA scans have been shown in studies 
to significantly correlate with the microarchitecture and strength of trabecular bone 
(Dong, et al., 2015). 
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1.6 Purpose of this Study 
 The purpose of this study is to evaluate the precision of stochastic predictors 
derived from DXA scans.  Precision is described as the ability to reproduce the same 
results with no change to the subject of interest with identical methodology.  Accuracy is 
determined by looking at how much the measured value deviates from the true value. 
Although in this study we will not be able to fully determine the true value of BMD for 
subjects, values will be compared against each other.  This study will use both BMD 
values and stochastic predictors from DXA scans to determine the precision of both 
techniques. This study will also examine the precision of BMD measurements and 
stochastic predictors in different scan sites. 
 Precision error is sometimes used interchangeable with precision. With regards to 
biological changes in bone, it is possible to have different measurements with no real 
changes in physiology. To determine if a significant change has occurred, precision 
studies are used to quantify the precision of techniques. Precision for this study is 
expressed as the root-mean square standard deviation (RMS-SD) and root-mean-square 
% coefficient of variation (RMS-%CV). Currently, precision values for DXA are best at 
the PA lumbar spine, proximal radius, total hip and heel. This experiment will look 
specifically at the PA lumbar spine and total hip. 
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Chapter Two 
Materials and Methods 
2.1 Recruitment of Subjects  
The University of Texas at Tyler Institutional Review Board (IRB) approved the 
short-term precision study on October 11, 2014. (See Appendix A).  An informed consent 
form was distributed to participants before testing. Subjects were informed of what DXA 
scans test, how the data would be used, and an understanding of the risk associated with 
the study. (See Appendix B). The participants were instructed and informed on how the 
test was to be conducted and the information being gathered prior to DXA scan. 
Participation was voluntary with participants able to stop testing if unable or unwilling to 
continue. 
Postmenopausal women with no history of osteoporotic fractures and who did not 
have any metal in their bodies were used for study. Subjects were scanned three times in 
the anterior-posterior position. This is in accordance with guidelines from the 
International Society for Clinical Densitometry (ISCD) and the procedure from “Clinical 
Densitometry for Technicians.” These procedures take into account sample size and the 
amount of radiation that is allowed for participants. For 15 participants, 3 scans are 
recommended with the scans taken back to back. Repositioning of the participant was 
conducted between scans. The scans were performed in one day in order to control for the 
possibility of bone density change from one session to another.  
2.2 DXA Scans 
Scan sites for this study are the lumbar vertebrae and hip. Scans were conducted 
in express modes. The scans were conducted in the Lifespan Wellness Center on the first 
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floor of the Jean Lancaster Academic Wing of the Harrington Patriot Center at The 
University of Texas at Tyler. An ISCD certified technician would acquire each of the 
scans during one session. Two-dimensional images of specimens were obtained through a 
DXA (Hologic QDR Discovery W, Bedford, MA) machine operating in a fan beam mode 
(Figure 2). 
 
 
	
 
 Figure 2. Dual energy X-ray absorptiometry machine 
Body positioning followed the recommendations described by the ISCD. This 
method is described as the NHANES method (Blake, et al., 2013).  This procedure 
clearly addresses the use of a Hologic Anthropomorphic Spine Phantom (HASP) in order 
to conduct daily Quality Control (QC) test before testing. Once the spine phantom has 
been placed, the table conducts the scan. The system runs an automatic QC analysis 
(Figure 3). Once complete, the system prompts if the QC scan was successful or a failure 
(Figure 4). 
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Figure 3. Phantom Spine	
 
 
	
Figure 4. Quality Control Prompt	
 
When daily QC has successfully passed, the clinician prepared participants for scanning. 
Before testing, subjects were required to remove objects from their pockets and jewelry 
from their body. For hip scans, the subjects were instructed to lie in the supine position 
with their legs flat against the mat.  Subjects were positioned centered, the head position 
towards the far right (when facing the table) with the hip lying between the hash marks 
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on the mat. The clinician positioned the C-arm in a way that allows the laser to fall 2 
inches below the greater trochanter and over the center shaft of the femur. Once there, the 
clinician rotated the left leg (if unable, use of the right leg was used) inwards. In order to 
maintain the leg in this position, a foot brace was used (Figure 5). Subjects were asked to 
cross their arms and remain still for testing. After each scan, the technician repositioned 
the participant.  
 
	
Figure 5. Patient Positioning for Hip Scans	
For the lumbar spine, the clinician made sure that the spine is straight and centered on the 
table and that her shoulders were at the upper scan limit hash marks on the long edges of 
the table, to ensure the spine was within the scan area. The subject spine was straightened 
and a translucent pillow placed under their head. A large square cushion was placed 
underneath the subject’s legs to maintain the hips in 90 degrees of flexion while 
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maintaining their arms at their sides (Figure 6). The C- arm was position approximately 2 
inches below the iliac crest, with the horizontal line coinciding with the spine alignment. 
After each scan, the clinician repositioned the subject. 
 
	
Figure 6. Patient Positioning for Lumbar Spine	
    
In order to determine precision values, BMD values from the DXA scans (Figure 7 and 
Figure 8) were then transferred into an excel file. An excel worksheet for calculating 
precision values was provided by “Densitometry for Clinical Technicians” ( Bonnick, 
2012). The square root of the mean square coefficient of variance (RMS-%CV) (Figure 
9) was calculated to determine the reproducibility of the values. Following the precision 
study protocol, RMS-%CV was used to determine the least significant change (LSC).  
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Figure 7. Lumbar Spine DXA Scan Data 
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Figure 8. Hip DXA Scan Data	
	
Figure 9. Calculation of % Covariance	
2.3 BMD Map 
With the completion of the DXA scans, the raw files were then be exported and uploaded 
into the MATLAB program to begin construction of the variogram.  The study looked 
specifically at the hip and lumbar scan sites. The raw files from the hip and lumbar 
vertebrae were uploaded in order to build a BMD map that includes stochastic values 
(Figure 10). It is important that the area of interest from both the hip and spine represent 
both accurately (Figure 11). 
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2.4 Experimental Variograms and Stochastic Predictors 
The variograms used stochastic predictors to describe the distribution of BMD at the hip. 
This distribution correlates with the micro-architecture of bone. The variogram is 
expressed in two values: semi-variance and lag. An exponential variogram model was 
fitted over the BMD map for the DXA scans of the hip. The reason is that the 
experimental variogram of the BMD map at the hip increases monotonically from 
minimum to its maximum. After completion, the MATLAB program showed the 
constructed area of interest, a histogram of the z-values, the sill, lag, and nugget values, 
as well as the exponential model over the variogram (Figure 10) 
	
Figure 10.	Hip Variogram	
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Figure 11. Hip Area of Interest  
For the DXA scans at the spine, a hole- effect theoretical variogram model was used to fit 
over the variogram of the BMD map. The hole-effect model represented the trend of the 
spine variogram which decreased from its maximum to a local minimum and then 
increased again (Figures 12-15). 
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Figure 12. Vertebrae L1 Variogram  
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Figure 13. Vertebrae L2 Variogram  
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Figure 14. Vertebrae L3 Variogram  
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Figure 15. Vertebrae L4 Variogram  	
Once the stochastic values from the variogram have been obtained, the values were 
transferred into excel files in order to examine the precision of the values. The excel 
worksheet for calculating precision values is the same one provided by the previous 
studies ( Bonnick, 2012).  
2.5 Determine Precision Values  
The precision values were obtained from the BMD and stochastic predictors at the hip 
and spine. The square root of the mean square coefficient of variance (RMS-%CV) was 
calculated to determine the reproducibility of the values. It is used to determine the least 
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significant change (LSC). The procedure for determining RMS-%CV and the LSC are the 
same as the above for the determining precision values from DXA scans. In both cases, 
the LSC represents the magnitude of any real biological change. The ISCD recommends 
calculating the LSC for a 95% confidence level, which is done by multiplying the LSC by 
2.77. The ISCD suggests using the RMS-%CV or the root of the mean square standard 
deviation (RMS-SD). Both values have been used to determine the LSC. The ISCD has 
outlined acceptable values for both cases. The RMS-CV% was be compared using both 
values against the recommendations of the ISCD.  
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Chapter Three 
Results  
3.1 Population of Study 
 The demographic information of the participants involved within the study are shown in 
Table 1. Of the 16 participants, 15 were used in the calculation of precision values. One 
subject was unable to remain positioned on the DXA table. The subjects were all female, 
and were all >55 years of age. All of the subjects were postmenopausal women. The 
Body Mass Index (BMI) was calculated from the participant’s height and weight. The 
BMI was recorded for each of the participants. 
Table 1. Summary of Selected Participants 
Participants	 16	Sex	 Female	(All)	Weight	(lbs.)	 149.5	±	27.5	Height	(in)	 62.6	±	3.4	Body	Mass	Index	(kg/m2)	 26.9	±	5.2	Age	 71.9	±	12.0	
3.2 Correlations of DXA Measurements Reported by a Hologic Densitometer and 
Calculated by a customized MATLAB Program  
By using two different programs to measure the same values, it is important to see how 
well correlated the values were. If the values were uncorrelated, it would be very difficult 
to make any meaningful comparisons of the values. In this study, we have reported DXA 
measurements (BMD, BMC, and Area) from Hologic; meanwhile, BMD, BMC and Area 
were also calculated from the BMD map using the raw data of DXA scans.   The total 
BMD values for the hip and spine were highly correlated between the Hologic 
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densitometer and the MATLAB program (Figures 16 and 17). For the sub-areas of both 
the spine and hip, the values seemed to correlate to a less degree.  
 
Figure 16. Hip BMD Correlation   
 
Figure 17. Lumbar Vertebrae Area Correlation 
The calculated BMD, BMC, and Area for the programs were highly correlated. The R2 
value was recorded to show the strength of the correlation between the variables. This 
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included total and individual sites. It can be noted that the femoral neck (Table 2) had 
some of the highest variation in terms of area. For area, the positioning of the patient is 
critical to accurate area measurements. Rotation of the hip could increase or decrease the 
area in profile and increase or decrease the BMD value for the total and individual areas 
of the hip. The ability to properly process the data in the DXA Hologic QDR program 
also may contribute to the variation in the area. Another contributing factor to the lower 
R2 value for the hip could be the differences in the thresholding value for the variogram 
program. However, the correlation between the two imaging modalities remains high.  In 
both programs, the BMC was very highly correlated at the hip areas. It can be seen that 
the L1 vertebrae (Table 3) had the lowest R2 value across the categories. The ISCD 
mentioned the area and BMC for the L1 vertebrae (Table 3) are more susceptible to 
incorrect measurements. Again, rotation of the spine, lateral flexion, or artifacts may 
contribute to the differences in BMC and calculation of area for both imaging programs. 
The remaining three lumbar vertebrae (L2, L3 and L4) were highly correlated across 
area, BMC and total BMD. 
Table 2. DXA and Variogram Hip Correlation Values 
Area	of	Interest	 DXA	/	Variogram	Correlation	
DXA	/	Variogram	
Correlation	
DXA	/	Variogram	
Correlation	
	 BMD	(R2)	 BMC	(R2)	 Area	(R2)	
Femoral	Neck	 .97	 .965	 .783	
Inter.	Trochanter	 .800	 .970	 .930	
Trochanter	 .982	 .939	 .903	
Total	Hip	 .966	 .978	 .979	
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Table 3. DXA and Variogram Spine Correlation Values 
Area	of	Interest	 DXA	/	Variogram	
Correlation	
DXA	/	Variogram	
Correlation	
DXA	/	Variogram	
Correlation	
	 BMD	(R2)	 BMC	(R2)	 Area	(R2)	
Lumbar	
Vertebrae	1	
.761	 .898	 .989	
Lumbar	
Vertebrae	2	
.959	 .973	 .99	
Lumbar	
Vertebrae	3	
.993	 .99	 .998	
Lumbar	
Vertebrae	4	
.983	 .99	 .998	
Total	Lumbar	
Spine	
.991	 .994	 .991	
3.3 Derived Precision Values from Template 
The following tables (Table 4 and Table 5) show the precision values that were 
calculated using the template. These values are for 15 individuals tested 3 times on the 
same day by the same clinician. For this study, we look specifically at the RMS-CV% to 
understand the precision values of BMD, BMC and Area from both the DXA and 
Variogram calculations. The other values can be used to calculate the least significant 
change (LSC) needed on that given machine to properly diagnose a patient. For this 
study, the availability of these values was not included in assessing the reproducibility of 
the DXA images. When performing precision studies, determining the LSC is vital to 
understand the true effect of metabolic change occurring in the bone and regions in which 
the programs, machines, and clinicians may differ. The machine and clinician error are 
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components that affect the value of LSC. The LSC in BMD  that can be determined with 
95% confidence is 2.77 X CV (ISCD 2005).  
 
Table 4. Summary of DXA Total Hip Precision Values 
Group Total Hip Average BMD .874 (g/cm2) 
RMS-SD 0.008 (g/cm2) 
RMS-CV 0.009 
RMS-%CV 0.88 % 
LSC 0.0218 (g/cm2) 
LSC% 2.425 % 
 
Table 5. Summary of DXA Total Lumbar Vertebrae Precision Values 
Group	Total	Lumbar	Average	
BMD	
.983	(g/cm2)	
RMS-SD	 0.01	(g/cm2)	
RMS-CV	 0.01	
RMS-%CV	 1.00	%	
LSC	 0.0265	(g/cm2)	
LSC%	 2.761	%	
3.4 ISCD Guidelines for Short-Term Precision Values 
The assessment of the total hip and spine scan values also included individual sites used 
for diagnosis. The femoral neck is an important diagnosis site, as a low BMD count has a 
high implication of fracture at the hip, but has been stated to have poor reproducibility as 
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compared to the total hip. ISCD position is that the minimum acceptable precision for an 
individual technologist is 1.9% for the lumbar spine and 1.8% for the total hip. This is 
when the clinician conducts all scans on the same day. 
Percentage of CV for the total hip (0.8–1.69%), posterior–anterior (PA) spine 
(1.0–1.2%), femoral neck (1.11–2.2%) and trochanter (1.16–1.5%) has been established 
by the ISCD.  
3.5 Precision Values for the Hip 
The calculated precision values were to determine the reproducibility of two different 
measures between the programs. This included not only measuring individual sites, but 
also computed BMC and area measures. This relates to how total BMD is being 
calculated between the two programs The LSC is often calculated by determining the 
%CV. According to the ISCD, the minimum acceptable precision for an individual 
technologist at the hip is: 
Total Hip: 1.8%CV (LSC=5.0%) 
Femoral Neck: 2.5%CV (LSC=6.9%) 
The following tables include RMS-%CV for individual sections of the hip and the 
stochastic prediction values for both programs.  The total hip BMD precision value 
(Table 6, Table 7) shows a precision value for the total hip for DXA and Variogram falls 
within the recommend ISCD guidelines. The guidelines from the ISCD list the following 
precision values as acceptable for a clinician.  
Femoral neck (1.11–2.2%) and trochanter (1.16–1.5%). 
It should be noted that the individual areas did not meet the precision standards in neither 
the DXA nor Variogram programs (Table 6, Table 7).  Upon review, it is sufficed to say 
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that the area and BMC for both programs were highly correlated, but were not as precise 
as the total hip calculations. 
Table 6.  Precision Values of BMD, BMC and Area from DXA at the Hip 
Area	of	
Interest	
DXA	Precision	Values	
	 BMD	(RMS-%CV)	 BMC	(RMS-%CV)	 Area	(RMS-%CV)	
Femoral	
Neck	 2.05	 2.99	 2.4	
Inter.	
Trochanter	 2.15	 4.6	 3.4	
Trochanter	 1.86	 2.62	 4.84	
Total	Hip	 .88	 1.51	 1.2	
 
	
Table 7. Variogram Precision Hip Values  
Area	of	
Interest	 Variogram	Precision	Values	
	 BMD	(RMS-%CV)	 BMC	(RMS-%CV)	 Area	(RMS-%CV)	
Femoral	Neck	 3.01	 3.67	 3.26	
Inter.	
Trochanter	 1.94	 4.16	 3.53	
Trochanter	 2.64	 6.91	 6.42	
Total	Hip	 1.74	 2.81	 1.79	
	
The precision values of stochastic predictors are also presented for the hip (Table 8). 
There is not a known value for comparing the precision of stochastic values. But the 
variability of measures does give some insight into the viability of the measures as a 
clinician metric for measuring bone microarchitecture. These values are correlated with 
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the microarchitecture of the trabeculae. With regards to the previous tables, changes in 
area and BMC will change the area of measure and possibly orientation of the 
microarchitecture. Slight changes in positioning will increase the distribution values that 
are measured by the sill variance and range. The total hip precision values of the 
stochastic predictors also coincide with the other precision values BMD. The trend also 
remains that the precision values are lower at the sub-regions. 
Table 8. Hip Stochastic Precision Values  
Area	of	Interest	 Stochastic	Precision	Values	
	 Range	(RMS-%CV)	 Sill	Variance	(RMS-%CV)	
Femoral	Neck	 14.38	 15.41	
Inter.	Trochanter	 8.48	 6.54	
Trochanter	 12.38	 9.17	
Total	Hip	 5.63	 4.59	
	
3.6 Precision Values for the Lumbar Spine 
The recommendation from the ISCD is a minimal 1.9% SD (LSC=5.3) change in the 
lumbar spine for a given clinician posterior–anterior (PA) spine, or a (1.0–1.2%) CV. The 
precision values for DXA and the Variogram with regards to the total BMD are within 
recommended limits. BMC, Area, and stochastic values are also included to show the 
effectiveness of the programs in measuring BMD. The ISCD mentions the possibility for 
a number of variables to change the BMD values during measures. By looking at the 
measured BMC and area values, the individual programs ability to measures within 
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correct area, measure the correct BMD and its effect on the BMD values are analyzed. 
This is especially important with the lumbar spine. For the hip, only the proximal femur 
was examined. Only one bone had to be accounted for. For the lumbar spine, the area is 
vital to the ability of the scans to make proper BMD analysis. The reason being is if the 
area overlaps or cuts off sections of the 4 lumbar vertebrae, the BMD will be significantly 
affected. This could occur specifically at L1. The area and BMC precision values for L1 
are highest in both measurement programs (Table 9, Table 10). When this area is 
measured, there are several reasons to take precaution to derive an accurate measure of 
this vertebra using a DXA machine. The data tends to show how much these variables 
can change the accuracy of L1.  
 
Table 9. DXA Lumbar Vertebrae Values 
Area	of	Interest	 DXA	Spine	Values	
	 BMD	(RMS-%CV)	 BMC	(RMS-%CV)	 Area	(RMS-%CV)	
Lumbar	
Vertebrae	1	
.761	 3.31	 1.79	
Lumbar	
Vertebrae	2	
.959	 2.14	 1.35	
Lumbar	
Vertebrae	3	
.993	 2.31	 1.26	
Lumbar	
Vertebrae	4	
.983	 2.68	 1.52	
Total	Lumbar	
Spine	
.991	 1.29	 .82	
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Table 10. Variogram Lumbar Vertebrae Values 
Area	of	
Interest	 Variogram	Precision	Values	
	 BMD	(RMS-%CV)	 BMC	(RMS-%CV)	 Area	(RMS-%CV)	
Lumbar	
Vertebrae	1	 5.11	
5.55	 2.07	
Lumbar	
Vertebrae	2	 2.71	
3.06	 1.62	
Lumbar	
Vertebrae	3	 2.42	
3.02	 1.23	
Lumbar	
Vertebrae	4	 2.3	
2.61	 1.6	
Total	Lumbar	
Spine	 1.23	
1.5	 .99	
 
The stochastic precision values for the spine (Table 11), show the same correlation that is 
shown for the hip. Again, slight changes in positioning will increase the distribution 
values that are measured by the sill variance and range. The total spine precision values 
for the variogram could not be calculated because a computer with a large memory was 
needed to complete the computation. It can be assumed that the total spine would 
coincide with the other precision values in that they are lower than at the individual 
vertebrae regions. The L1 had the highest variation with the other sections of the spine 
having a lower CV% value. The trend may have remained the same for the total spine. 
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Table 11. Spine Stochastic Precision Values 
Area	of	Interest	 Stochastic	Precision	Values	
	 Range	(RMS-%CV)	 Sill	Variance	(RMS-%CV)	
Lumbar	Vertebrae	1	 13.42	 14.59	
Lumbar	Vertebrae	2	 13.91	 11.92	
Lumbar	Vertebrae	3	 13.24	 8.68	
Lumbar	Vertebrae	4	 11.75	 9.91	
Total	Lumbar	Spine	 	 	
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Chapter Four 
Discussion and Conclusions 
4.1 Findings 
The main finding of our study was that the reproducibility of stochastic predictors for 
both the lumbar and hip region was lower than the BMD values at both regions. The 
amount of variance at both of these regions could be explained by the inhomogeneity the 
stochastic values represent. That is, stochastic values are representations of bone 
variation. Specifically, the stochastic predictors represent the variation of micro-
architecture of bone. This variation within the bone could possibly contribute to higher 
variation of measures when computed into a precision study. It was noted that the first 
and second lumbar vertebrae seemed to have hole-effect variograms that did not seem to 
fit as well as the third and fourth lumbar vertebrae. The DXA and Variogram models 
seem to correlate very well in terms of precision values. To a lesser extent, the spine 
DXA and Variograms also had total BMD values that correlated very well and have an 
acceptable precision value. Both programs did have higher CV% when looking at 
individual area for both the hip and lumbar spine. It can be assumed that the programs 
were highly correlated, but the calculated values and imaging areas did change between 
the programs. This precision study did find that stochastic predictors are a viable option 
for assessing the micro-architecture of the trabeculae at the lumbar spine and hip. The 
total calculated BMD at both areas was the most precise measure at both the hip and 
lumbar spine. There does remain more work to be done over the Variogram in order to 
reduce the variation of the measures.  
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4.1.1 Strengths and Limitation of this Study 
	 Within this study, the use of one clinician and same day scans was able to 
decrease the precision error of the scans. This coincided with the literature involving the 
use of same day scans. (Leslie, D. W, 2008). The ability to scan on the same day is 
recommended by the ISCD to add validity to the study. By scanning on the same day, the 
variance between the measures is assumed to be solely from precision error. The idea that 
any metabolic changes could have caused variance can be dismissed by conducting all of 
the scans on the same day. The participants in this study were also considered healthy. 
No signs of fracture, additional vertebrae, or inability to scan a given area due to injury or 
surgery occurred. 
4.2 Limitations of this Study 
A limitation our study the study is lack of information on precision values of 
stochastic predictors and bone micro-architecture. Currently, there is no data on the use 
of stochastic predictors with which to compare our results  
Our data are consistent with previous studies involving BMD values for the 
lumbar and hip region. Another commonly cited issue with precision studies is that the 
data are only applicable for the study’s densitometer and clinicians. The data may or may 
not be transferable to different densitometer machines, models or clinicians. The values 
recorded are not only a representation of the equipment but also the skill of the 
technician. It should also be mentioned that the clinician used in our study is 
representative of her own skills. That is, with more clinicians, the room for error will 
increase depending on each individual’s skill. But this representation of a single 
technician may or may not accurately represent what would occur in a clinical setting.  
These values are applicable to only those subjects within our study and the clinician 
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conducting the scans. Another limiting factor was that our convenience sample did not 
include any males.   
The use of same day testing for DXA scans has been reported to decrease the 
amount of precision error within the study. However, the use of same day scans does not 
accurately represent the real life clinical application of DXA scans. These scans would be 
taken over the course of weeks, months or years. Although the long terms studies do 
more accurately represent clinical DXA scans, it has been documented that short term 
precision studies have lower precision errors as compared to long term precision studies 
(Leslie, W. 2008) (Bonnick, 2001). As the time is increased between scans, so does the 
probability for error.   
 Frequently, L1 tends to have lower BMD values than the other lumbar vertebrae. 
A common area for error in DXA measurements, it is a commonly fractured area and can 
be mistaken for thoracic vertebra 12. The presence of a 6th lumbar disk can also affect the 
ability of the programs to properly asses BMD. For our study, none of these issues 
seemed to occurred. For the lumbar scans, one subject was seen to be an outlier for the 
study. Upon reviewing the scans, it seemed as if there was an artifact over one of the 
vertebrae that seemed to be skewing the data. The measurements that were derived for 
both the lumbar BMD and the stochastic values more than likely also contributed to the 
variation between the scans. 
4.3 Comparison from Previous findings 
From previous studies, BMD precision at the hip was said to be higher than that 
of lumbar values (Blake, et al., 2013). In this precision study, we found the same 
correlation. The lumbar vertebrae are said to be more susceptible to metabolic changes 
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that change BMD and are often used to monitor treatment for this reason. Studies have 
also shown no significant difference between different imaging modes in terms of 
precision. For our study, the fast array mode did not show significant disparities in the 
precision values stated by the ISCD at the specific image sites. Not only does this mean 
that BMD values being computed in lower scan modes are not significantly more 
inaccurate, the site selection did not affect BMD significantly. Our study used lower 
resolution scan modes to not only decrease the amount of radiation the subjects would be 
exposed to for the back to back scans, but also cut down on the acquisition time for the 
project.  
4.4 Final Conclusions and Recommendations for Future Studies 
The participants within the study were found to be healthy with no detectable 
bone fractures. By looking at a healthy population, who were free of metal implants in 
their bodies, the error associated with improper DXA values in a fractured bone were also 
controlled. The effects of fractures on BMD have been studied. For the variogram, there 
has only been data compiled over the correlation of the micro-architecture of bone and 
the sill value in regards to un-fractured bones. Future studies should look at how fractures 
affect the variogram stochastic values.  
Within our study, we did not compute the stochastic values for the entire spine, 
due to insufficient computational memory to run the program. In both the lumbar spine 
and hip, the total area of the scan sites as opposed to specific sites showed significant 
improvement in precision values for BMD. For the total hip, the trend seemed to carry 
over for the stochastic values as well. Currently, it can only be speculated that this may 
have also been the cause for the total spine stochastic values.	
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The hole-effect model used over the individual lumbar vertebrae should be 
improved upon. The current model fitted over the variogram is a simple hole-effect 
model that seemed to inaccurately measure the lag. A hole-effect model is used to plot 
the cyclical amplitudes of a variable. The hole-effect model is often the result of some 
ordered periodicity in the data. A hole-effect model using the sine function on lumbar 
vertebrae instead of exponential for hip is also a concern. This basic model that was 
constructed does not correctly match over the three slopes from the mapped variogram 
model. It only works on some of the variogram models, particularly L3-L4.   
This study looked into using stochastic predictors to quantitatively describe the 
natural variables of micro-architecture as distributed in a given space. The variogram 
modeling in this project is used to make predictions from data on the spatially variable 
properties of bone. Although quantified, the spatial properties of bone with the use of 
variograms are still in development. There is still a need to fully bridge the functional 
relationship between stochastic predictors and micro-architecture of bones.  
BMD is only a part of what constitutes healthy bones. The ability to resist 
fractures also depends on the micro-architecture of bone. For this reason, many clinicians 
use age, family history of fractures, history of fractures, illnesses and treatments that may 
cause osteoporosis. The use of stochastic predictors, along with BMD, a new holds 
promise to diagnose and treat osteoporosis holds since it has the ability to aid in the 
understanding of the microarchitecture at different scan sites. 
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Appendix A 
Internal Review Board approval 
	
	
	
Office	of	Research	and	
Technology	Transfer	
	
Institutional	Review	Board	
	
	June	4,	2015		Dear	Dr.Dong,		Your	request	to	conduct	the	study: A	Short-term	Precision	Study	of	DXA,	IRB#	SUM2015-92, has	been	approved	by	The	University	of	Texas	at	Tyler	Institutional	Review	Board	under	expedited	review.	This	approval	includes	the	written	informed	consent	that	is	attached	to	this	letter,	and	your	assurance	of	participant	knowledge	of	the	following	prior	to	study	participation:	this	is	a	research	study;	participation	is	completely	voluntary	with	no	obligations	to	continue	participating,	and	with	no	adverse	consequences	for	non-participation;	and	assurance	of	confidentiality	of	their	data.				In	addition,	please	ensure	that	any	research	assistants	are	knowledgeable	about	research	ethics	and	confidentiality,	and	any	co-investigators	have	completed	human	protection	training	within	the	past	three	years,	and	have	forwarded	their	certificates	to	the	IRB	office	(G.	Duke).		
Please	review	the	UT	Tyler	IRB	Principal	Investigator	Responsibilities,	and	
acknowledge	your	understanding	of	these	responsibilities	and	the	following	
through	return	of	this	email	to	the	IRB	Chair	within	one	week	after	receipt	of	
this	approval	letter:		
• This	approval	is	for	one	year,	as	of	the	date	of	the	approval	letter	
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• The	Progress	Report	form	must	be	completed	for	projects	extending	
past	one	year.	Your	protocol	will	automatically	expire	on	the	one	year	anniversary	of	this	letter	if	a	Progress	Report	is	not	submitted,	per	HHS	Regulations	prior	to	that	date	(45	CFR	46.108(b)	and	109(e):	http://www.hhs.gov/ohrp/policy/contrev0107.html	
• Prompt	reporting	to	the	UT	Tyler	IRB	of	any	proposed	changes	to	this	research	activity	
• Prompt	reporting	to	the	UT	Tyler	IRB	and	academic	department	
administration	will	be	done	of	any	unanticipated	problems	involving	
risks	to	subjects	or	others	
• Suspension	or	termination	of	approval	may	be	done	if	there	is	evidence	of	any	serious	or	continuing	noncompliance	with	Federal	Regulations	or	any	aberrations	in	original	proposal.	
• Any	change	in	proposal	procedures	must	be	promptly	reported	to	the	IRB	prior	to	implementing	any	changes	except	when	necessary	to	eliminate	apparent	immediate	hazards	to	the	subject.			Best	of	luck	in	your	research,	and	do	not	hesitate	to	contact	me	if	you	need	any	further	assistance.		Sincerely,		
	Gloria	Duke,	PhD,	RN	Chair,	UT	Tyler	IRB	
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Appendix B 
Patient consent form 
 
  
THE UNIVERSITY OF TEXAS AT TYLER 
Informed Consent to Participate in Research 
Institutional Review Board #Sum2015-92 
Approval Date: June 3, 2015 
 
1. Project Title: A Short-Term Precision Study of DXA  
 
2. Principal Investigator: X. Neil Dong 
  
3. Participant Name: 
 
4. Simple Description of Project Purpose: This main purpose of this study 
is to determine the precision of bone density testing equipment at The 
University of Texas at Tyler. We invite you to participate in this research 
study where your bone density will be measured by the equipment housed 
in the Lifespan Wellness Center on the first floor of the Jean Lancaster 
Academic Wing of the Harrington Patriot Center at The University of 
Texas at Tyler. 
5. Research Procedures: If you agree to be in this study, we will ask 
you to do the following things: 
In order to protect your privacy, all testing described below will be 
performed with only the tester(s) and you present. 
In order to take the test, you will be asked to come dressed comfortably in 
clothing (e.g., sweat suit, or shorts and t-shirt or any clothing that contains no 
metal zippers or buttons). Gowns will be available, if needed. We will also ask 
you to remove all jewelry and watches and to be sure that your pockets do 
not contain keys or other objects in metal. Objects containing metal may 
cause the machine to give us incorrect readings. 
Your bone density test will be made using a machine called a DXA (Dual-
energy X-ray Absorptiometry) made by the leading manufacture of DXA 
equipment (Hologic QDR Discovery W). The persons doing the testing with 
this equipment have had special training and are license certified. Just before 
getting on the DXA machine for testing, you will be asked to remove your 
shoes. The DXA testing will involve having you lie on your back in a stationary 
position on the DXA exam table for about 7 minutes. Your feet will be taped 
together with paper tape, to keep them from moving if you get too relaxed 
during the test. 
 
54	
	
6. Potential Risks:  
No foreseeable side effects are expected as a result of the testing of this 
study. You will be exposed to a low level of radiation during the bone density 
test that is similar to the natural radiation you would receive during the flight 
from Dallas to Los Angeles. The use of DXA equipment has been shown to 
be safe, has been in use since the early 1990s and has been approved by the 
FDA. But please keep in mind that unpredicted risks may exist. 
7. Potential Benefits:  
As a participant you will receive a printed copy of your bone density test 
with a T-score. The T-score will tell you if you are at risk for osteoporosis. 
 
Understanding of Participants: 
 
8. I have been given a chance to ask any questions about this research 
study. The researcher has answered my questions. I understand any and 
all possible risks. 
 
9. If I sign this consent form I know it means that: 
 
• I am taking part in this study because I want to. I chose to take part 
in this study after having been told about the study and how it will 
affect me. 
 
• I know that I am free to not be in this study.  If I choose to not take 
part in the study, then nothing will happen to me as a result of my 
choice. 
 
• I know that I have been told that if I choose to be in the study, then I 
can stop at any time. I know that if I do stop being a part of the 
study, then nothing will happen to me. 
 
 
10. I have been promised that that my name or other identifying information 
will not be in any reports (presentations, publications) about this study 
unless I give my permission. The UT Tyler Institutional Review Board (the 
group that makes sure that research is done correctly and that procedures 
are in place to protect the safety of research participants) may look at the 
research documents. This is a part of their monitoring procedure and will 
be kept confidential.  
 
11. If I have any questions concerning my participation in this project, I will 
contact the principal researcher: Dr. X. Neil Dong, 930-565-5615, 
ndong@uttyler.edu.   
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12. If I have any questions concerning my rights as a research subject, I will 
contact Dr. Gloria Duke, Chair of the IRB, at (903) 566-7023, 
gduke@uttyler.edu. 
 
CONSENT/PERMISSION FOR PARTICIPATION IN THIS RESEARCH STUDY 
 
I have read and understood what has been explained to me. I give my 
permission to take part in this study as it is explained to me. I give the 
study researcher permission to register me in this study. I have received a 
signed copy of this consent form. 
 
_____________________________   _ ___  _ __________     _________ 
Signature of Participant  Date 
 
_____________________________________  
Witness to Signature  
 
13. I have discussed this project with the participant, using language that is 
understandable and appropriate. I believe that I have fully informed this 
participant of the nature of this study and its possible benefits and risks. I 
believe the participant understood this explanation. 
 
 
  _________________________________ _______________ 
  Researcher/Principal Investigator    Date 
 	
 	
 
 
 
 
 
 
 
